Replies to post #33816 on Inovio Pharmaceuticals Inc (INO)

[gastric]

It immediately kills the expected catalyst of starting P2/3 in September, as specifically stated by Kim last week.

Market clearly is reacting.

No need to overreact

INOVIO PHARMA - PARTIAL CLINICAL HOLD IS NOT DUE TO OCCURRENCE OF ANY ADVERSE EVENTS RELATED TO INOVIO'S ONGOING EXPANDED PHASE 1 STUDY OF INO-4800

[The Canes]

The problem is we're already way behind several other studies. There could be two or three vaccines approved by the time they're half way enrolled in Phase 2/3. So yes there's a really good reason to react negatively to this news. This is a race. We're not even out of the blocks yet!

[OilPatch]

LOL, down 30% on a partial hold and you want peeps not to overreact? LOL.

Lots of $$$ going down the toilet atm, peeps should do what they want.